Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT02065349 Completed - Neuropathic Pain Clinical Trials

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety

MOBILE
Start date: February 24, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the painkilling efficacy of ASP8477 relative to mock (placebo) in patients that have been diagnosed with painful diabetic peripheral neuropathy or postherpetic neuralgia determined by the change in the average daily pain intensity in patients that initially respond favorably to treatment with ASP8477.

NCT ID: NCT02064530 Completed - Pain Clinical Trials

Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block

TAP
Start date: February 2014
Phase: Phase 4
Study type: Interventional

the aim of this study is evaluate postoperative analgesic effects of dexmedetomidine added to bupivacaine on TAP block in patients undergoing lower abdominal surgery.

NCT ID: NCT02063698 Completed - Pain Clinical Trials

Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome

Start date: February 19, 2014
Phase: Phase 2
Study type: Interventional

This randomized pilot clinical trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain. Auranofin is a drug given by mouth to treat other diseases such as rheumatoid arthritis, and is being studied to see if it will decrease pain following paclitaxel.

NCT ID: NCT02055235 Completed - Pain Clinical Trials

Study of Pain Processing in Experienced Yoga Practitioners

Start date: January 27, 2014
Phase: N/A
Study type: Observational

Background: - Different people perceive the same pain differently. Mood, attention, stress, and personality affect how we feel pain. Researchers want to know whether people who do yoga perceive pain differently than people who do not practice yoga, meditation, or martial arts. They also want to study if cortisol, a stress hormone, relates to pain or brain differences. Objective: - To study the effects of yoga on the body s stress response, pain perception, and the brain s structure and pain response. Eligibility: - Right-handed adults 30 years and older who practice yoga regularly. - Healthy right-handed volunteers 30 years and older who do at least mild exercise but no yoga or martial arts. Design: - Visit 1: Participants will be screened with medical history and physical exam. They will have blood and urine tests and electrocardiogram to measure heart activity. - At home, participants will wear a heart monitor for 1 day and collect 5 saliva samples daily for seven days. - Visit 2: Participants will undergo tests in a chair or in a mock MRI machine. They will lie on a table that slides into a cylinder. - A heating device will be placed on their leg and heated periodically for few seconds at a time. - They will give saliva samples. - Heart rate, respiration, etc. will be monitored. - They will fill out questionnaires. - Visit 3: Participants will answer questions and repeat Visit 2 tests. Tests will be done in the real MRI machine. The scanner makes loud knocking sounds. Participants will get earplugs. Participants will be in the scanner about 1 hour with a coil over their head.

NCT ID: NCT02050490 Completed - Pain Clinical Trials

Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study

Start date: January 2014
Phase:
Study type: Observational

This study investigates whether the implementation of a symptom diary for reporting and communicating chemotherapy-related symptoms improves symptom care and decreases symptom burden in adult patients treated with chemotherapy. The hypothesis is studied using a before-and-after design. First, symptom care and symptom burden will be observed in a sample of patients not being offered a symptom diary. Next, the symptom diary will be implemented at the participating hospital and symptom care and symptom burden will now be observed in a new sample of chemotherapy patients.

NCT ID: NCT02049255 Completed - Pain Clinical Trials

Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

Start date: November 2013
Phase: Phase 4
Study type: Interventional

Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months) pain.

NCT ID: NCT02049086 Completed - Pain Clinical Trials

Pain Management for Veterans Filing Compensation Claims

SBIRT LBP
Start date: March 2014
Phase: N/A
Study type: Interventional

This proposal will develop and test an indicated prevention strategy, Screening, Brief Intervention and Referral to Treatment with Pain-Management advice (SBIRT-PM), in Veterans who have filed a claim for a (military) service-connected injury for which they have requested financial compensation. Although typically only an information-gathering, forensic-styled examination, the Compensation examination is a crucial point of entry to VA care. Objectives are: 1. To finalize the procedures, manual, and training materials of SBIRT-PM. The goals of this stage will be (1) optimizing SBIRT-PM's appeal to Veterans concerned about their musculoskeletal conditions and their Compensation claims; and (2) finalizing the counseling materials and procedures. 2. To conduct a randomized clinical trial comparing SBIRT-PM to a no referral arm and a pain module only arm.

NCT ID: NCT02048293 Completed - Pain Clinical Trials

Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules

Start date: October 2012
Phase: Phase 4
Study type: Interventional

Unbranded drug molecules are produced after the patent of a given drug has expired. Unbranded molecules of Remifentanil have been marketed in Colombia, and several reports by anesthesiologist indicate that there are differences in the physiologic response of patients to these molecules. The investigators hypothesized that unbranded molecules of remifentanil require higher doses to obtain desired physiological responses as compared to the branded molecule.

NCT ID: NCT02043366 Completed - Pain Clinical Trials

Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients

Start date: February 2014
Phase: N/A
Study type: Interventional

Purpose: To explore and compare antihyperalgesic effects of butorphanol, flurbiprofen axetil, and a combination of both received before anesthesia induction. To evaluate and examine the incidence of adverse effects with the purpose of selecting the optimum dose.

NCT ID: NCT02039661 Completed - Pain Clinical Trials

Effect of Lidocaine Spray for Pain Relief During Endometrial Biopsy: a Randomized, Double-blind, Placebo-controlled Clinical Trial

Start date: November 2013
Phase: N/A
Study type: Interventional

The effect of lidocaine spray on pain relief during endometrial sampling.